Heres what each one does to potentially help with weight loss, what the research shows, and whether it makes a difference
MET-097i, a once-monthly subcutaneous injection, is one of the two centerpieces of the buyout, being the backbone asset for the biotechs obesity strategy
Studies have included people with a BMI of 30 kg/m or higher, as well as individuals with a BMI of 27 kg/m or higher alongside conditions such as high blood pressure, sleep apnoea or type 2 diabetes
Drugs Context 12:15
You should NOT take these medications if you have a history of medullary thyroid cancer, history of gallbladder disease, history of pancreatitis, or multiple endocrine neoplasia type 2 (MEN2)
Patients with body fat above 25% require 1.25-inch needles to reach muscle tissue reliably